Treating eyelid mites in scleral lens wearers
Part of Eyes & vision clinical trials.
This study tests a medicated eye drop (lotilaner) to treat eyelid mite inflammation (Demodex blepharitis) in people who wear PROSE scleral lenses. It aims to see if the drops safely reduce symptoms like redness, itching, and blurry vision.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have worn PROSE scleral lenses in both eyes every day for more than 6 months
- You have signs of Demodex blepharitis (more than 10 mites at the base of your upper eyelashes) in both eyes
- You have symptoms like redness, itching, burning, blurred vision, or discomfort that bother you regularly
- You have not changed your lens design recently and do not plan to during the study
- You are not using any new eyelid or eye surface treatments for blepharitis in the last 3 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an investigational eye drop (GLK-321) to see if it safely and effectively treats Demodex blepharitis, an eyelid inflammation caused by tiny mites. It may help people who have signs of this condition and good enough vision.
This study looks at whether PROSE or scleral lenses can improve mental health in people with certain eye surface conditions. It may be a good fit if you have a dry eye or related disease and are considering these lenses.
This study tests whether over-the-counter lubricating eye drops can improve dry eye symptoms and eye comfort. It compares the drops to no treatment to see how well they work.
This Phase 3 study compares two topical (applied to the eye) treatments to reduce inflammation-related irritation in people who wear a permanent eye prosthesis. It may help if your prosthesis-related eye discomfort is ongoing despite basic care like artificial tears.
This study tests two types of preservative-free eye drops to see which is more effective for people with mild to moderate dry eye disease. You will use one of the drops as directed, and the study will monitor your symptoms and eye health over time.
This trial tests a new type of eye drop (called VMX) to see if it helps people with mild to moderate dry eye. The study will compare how well the eye drops work and if they are safe for you to use.
Hear when a new Demodex Blepharitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.